NASDAQ:NUTX Nutex Health (NUTX) Stock Price, News & Analysis → Trump’s last act as President (From Porter & Company) (Ad) Free NUTX Stock Alerts $0.61 +0.00 (+0.17%) (As of 05:27 PM ET) Add Compare Share Share Today's Range$0.60▼$0.6350-Day Range$0.53▼$1.7752-Week Range$0.50▼$9.24Volume42,290 shsAverage Volume236,383 shsMarket Capitalization$30.13 millionP/E RatioN/ADividend YieldN/APrice Target$15.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Nutex Health alerts: Email Address Nutex Health MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside2,375.2% Upside$15.00 Price TargetShort InterestHealthy0.62% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.33Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.02 out of 5 starsMedical Sector364th out of 927 stocksBusiness Services, Not Elsewhere Classified Industry48th out of 88 stocks 3.5 Analyst's Opinion Consensus RatingNutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageNutex Health has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.62% of the float of Nutex Health has been sold short.Short Interest Ratio / Days to CoverNutex Health has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutex Health has recently decreased by 82.64%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldNutex Health does not currently pay a dividend.Dividend GrowthNutex Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NUTX. Previous Next 2.4 News and Social Media Coverage News SentimentNutex Health has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Nutex Health this week, compared to 1 article on an average week.Search InterestOnly 5 people have searched for NUTX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows6 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nutex Health insiders have not sold or bought any company stock.Percentage Held by Insiders48.48% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 5.32% of the stock of Nutex Health is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nutex Health is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nutex Health is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNutex Health has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyTrump just won 2024President Trump signed an executive order that ensures he’ll be remembered as one of America’s greatest Presidents. It was an Executive Order that received almost no media attention…For the full story, click here. About Nutex Health Stock (NASDAQ:NUTX)Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.Read More NUTX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NUTX Stock News HeadlinesApril 29, 2024 | prnewswire.comNUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCEApril 29, 2024 | prnewswire.comNUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCEMay 1, 2024 | Banyan Hill Publishing (Ad)READ THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”April 22, 2024 | prnewswire.comNUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORSApril 16, 2024 | prnewswire.comNutex Health Hospitals Gain Community Recognition and Take Home Seven Patient Satisfaction Awards in Q1April 12, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Provides Corporate UpdateApril 12, 2024 | prnewswire.comNUTEX HEALTH PROVIDES CORPORATE UPDATEApril 8, 2024 | finance.yahoo.comNUTEX HEALTH OPENS FIRST HOSPITAL OF 2024 IN BELLEVUE, WISCONSINMay 1, 2024 | Banyan Hill Publishing (Ad)READ THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”April 5, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Announces 1-for-15 Reverse Stock SplitApril 5, 2024 | investorplace.comWhy Is Nutex Health (NUTX) Stock Down 13% Today?April 5, 2024 | prnewswire.comNUTEX HEALTH ANNOUNCES 1-FOR-15 REVERSE STOCK SPLITApril 1, 2024 | investorplace.comNUTX Stock Earnings: Nutex Health Misses Revenue for Q4 2023March 29, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Reports Fourth Quarter And Full Year 2023 Financial ResultsMarch 28, 2024 | finance.yahoo.comNUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTSMarch 18, 2024 | investorplace.com3 Promising Penny Stocks You Can Pick Up for Less Than a QuarterMarch 15, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Announces Preliminary 2023 Headline Financials And Provides Update On The Timing Of Its 10-k FilingMarch 15, 2024 | prnewswire.comNUTEX HEALTH ANNOUNCES PRELIMINARY 2023 HEADLINE FINANCIALS AND PROVIDES UPDATE ON THE TIMING OF ITS 10-K FILINGFebruary 23, 2024 | benzinga.comNutex Health Stock (NASDAQ:NUTX), Analyst Ratings, Price Targets, PredictionsFebruary 5, 2024 | msn.comNutex Health's Medicare Advantage membership doublesFebruary 5, 2024 | finance.yahoo.comNUTEX HEALTH ANNOUNCES OVER 100% INCREASE IN MEDICARE ADVANTAGE ENROLLMENTJanuary 31, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Announces Streamlined Strategic PlanJanuary 30, 2024 | finance.yahoo.comNUTEX HEALTH ANNOUNCES YORKVILLE PAYOFF AND STREAMLINED STRATEGIC PLANJanuary 23, 2024 | markets.businessinsider.comNutex Prices Direct Offering, Stock Plummets In Pre-marketJanuary 23, 2024 | finance.yahoo.comNutex Health Announces Pricing of $10.0 Million Registered Direct Offering of Common Stock and WarrantsJanuary 18, 2024 | finance.yahoo.comNutex Health Inc.'s (NASDAQ:NUTX) top owners are retail investors with 47% stake, while 43% is held by insidersDecember 18, 2023 | finance.yahoo.comNUTEX HEALTH TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCESee More Headlines Receive NUTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today5/01/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Business services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:NUTX CUSIPN/A CIK1479681 Webwww.nutexhealth.com Phone(713) 660-0557Fax631-670-6780Employees800Year FoundedN/APrice Target and Rating Average Stock Price Target$15.00 High Stock Price Target$15.00 Low Stock Price Target$15.00 Potential Upside/Downside+2,359.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.1994) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-45,790,000.00 Net Margins-18.49% Pretax Margin-19.58% Return on Equity-45.58% Return on Assets-10.50% Debt Debt-to-Equity Ratio3.04 Current Ratio1.56 Quick Ratio1.50 Sales & Book Value Annual Sales$247.65 million Price / Sales0.12 Cash FlowN/A Price / Cash FlowN/A Book Value$1.77 per share Price / Book0.34Miscellaneous Outstanding Shares49,720,000Free Float25,616,000Market Cap$30.32 million OptionableNot Optionable Beta0.44 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Thomas T. Vo M.B.A. (Age 51)M.D., Chairman of the Board & CEO Comp: $938.23kDr. Warren Hosseinion M.D. (Age 52)President & Director Comp: $937.66kMr. Jon C. Bates CPA (Age 53)M.B.A., Chief Financial Officer Comp: $299.46kMs. Pamela W. Montgomery B.S.N. (Age 58)J.D., L.L.M., M.S.N., R.N., Chief Legal Officer of Healthcare & Board Secretary Comp: $275.36kMs. Elisa Michael Luqman Esq. (Age 60)J.D., M.B.A., Chief Legal Officer (SEC) & Board Secretary Comp: $251.33kMr. Joshua DeTillio FACHEM.B.A., Chief Operating OfficerMs. LaChoenda RosalesDirector of AccountingLaTanya BrackensDirector of ComplianceMs. Vivian Sanders M.B.A.Director of MarketingSarah WallaceDirector of Human ResourcesMore ExecutivesKey CompetitorsAchilles TherapeuticsNASDAQ:ACHLDURECTNASDAQ:DRRXSingular Genomics SystemsNASDAQ:OMICCASI PharmaceuticalsNASDAQ:CASINeuroOne Medical TechnologiesNASDAQ:NMTCView All CompetitorsInsiders & InstitutionsOne Plus One Wealth Management LLCBought 5,043,720 shares on 4/10/2024Ownership: 0.710%Beaird Harris Wealth Management LLCBought 630,168 shares on 2/27/2024Ownership: 0.139%GDS Wealth ManagementBought 550,026 shares on 2/7/2024Ownership: 0.165%Truist Financial CorpBought 2,018,966 shares on 2/2/2024Ownership: 0.651%Thomas T VoBought 18,346 shares on 11/20/2023Total: $63,293.70 ($3.45/share)View All Insider TransactionsView All Institutional Transactions NUTX Stock Analysis - Frequently Asked Questions Should I buy or sell Nutex Health stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutex Health in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NUTX shares. View NUTX analyst ratings or view top-rated stocks. What is Nutex Health's stock price target for 2024? 1 brokerages have issued 12 month target prices for Nutex Health's shares. Their NUTX share price targets range from $15.00 to $15.00. On average, they predict the company's share price to reach $15.00 in the next year. This suggests a possible upside of 2,375.2% from the stock's current price. View analysts price targets for NUTX or view top-rated stocks among Wall Street analysts. How have NUTX shares performed in 2024? Nutex Health's stock was trading at $2.70 on January 1st, 2024. Since then, NUTX stock has decreased by 77.6% and is now trading at $0.6060. View the best growth stocks for 2024 here. Are investors shorting Nutex Health? Nutex Health saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 178,800 shares, a decrease of 82.6% from the March 31st total of 1,030,000 shares. Based on an average daily volume of 275,800 shares, the short-interest ratio is presently 0.6 days. Currently, 0.6% of the shares of the stock are sold short. View Nutex Health's Short Interest. When is Nutex Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our NUTX earnings forecast. How were Nutex Health's earnings last quarter? Nutex Health Inc. (NASDAQ:NUTX) released its quarterly earnings data on Thursday, March, 28th. The company reported ($0.75) earnings per share for the quarter. The firm earned $69.67 million during the quarter. Nutex Health had a negative net margin of 18.49% and a negative trailing twelve-month return on equity of 45.58%. When did Nutex Health's stock split? Shares of Nutex Health reverse split on the morning of Wednesday, April 10th 2024. The 1-15 reverse split was announced on Wednesday, April 10th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. Who are Nutex Health's major shareholders? Nutex Health's stock is owned by a number of retail and institutional investors. Top institutional investors include One Plus One Wealth Management LLC (0.71%). Insiders that own company stock include John J Waters, Joshua Detillio, Michael Lee Reed, Pamela W Montgomery and Thomas T Vo. View institutional ownership trends. How do I buy shares of Nutex Health? Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NUTX) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlace😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget Nvidia. This is the future of AIPorter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutex Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
